Staged Signaling for Spinal Motor Neuron Subtype Specification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating human pluripotent stem cells (hPSCs) into spinal motor neurons (sMNs) with defined rostro-caudal identities are inefficient and lack precision, leading to mixed identities and contamination with non-neuronal cells, which hampers the generation of specific MN subtypes essential for disease modeling and regenerative medicine.
Innovation Solution
A method involving embryoid body-based differentiation of hPSCs, where the duration and combination of Wnt and Retinoic Acid exposure, along with Fibroblast Growth Factor (FGF) and Growth Differentiation Factor (GDF) signaling, control the temporal activation of HOX genes, allowing for the precise engineering of spinal motor neuron subtypes with defined rostro-caudal identities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional differentiation methods are used to generate spinal motor neurons from hPSCs, then motor neuron populations can be obtained, but the cells exhibit mixed rostro-caudal identities and are contaminated with non-neuronal cells
Solution Approach 1:
The invention changes key parameters of the differentiation protocol: (1) Timing parameters - staged addition of RA at specific days (D0, D3, D6) to control HOX gene activation sequence; (2) Concentration parameters - optimized concentrations of RA (100nM), Wnt3a (100ng/mL), and FGF8 (100ng/mL); (3) Duration parameters - controlled exposure times for each factor. These parameter changes enable precise temporal control of HOX clock activation, achieving pure populations of specific MN subtypes (e.g., lumbar MNs expressing HOX C6-C10) without mixed identities or non-neuronal contamination
Solution Approach 2:
The invention implements dynamic control of the differentiation process by sequentially adding and removing signaling factors at defined time points. The HOX clock is dynamically regulated through: (1) Initial RA exposure to activate 3' HOX genes; (2) Wnt3a addition to maintain progenitor state and prepare for caudal identity; (3) FGF8 addition to drive progressive HOX gene activation; (4) Gamma-secretase inhibitor application to promote neuronal differentiation. This dynamic protocol transforms static mixed populations into dynamic pure populations of defined rostro-caudal identities
2Productivity
If the differentiation process is accelerated to improve productivity, then cell generation time is reduced, but control over cell fate specification becomes imprecise
Solution Approach 1:
The invention performs preliminary actions to prepare the system for precise subsequent control: (1) hPSCs are pre-conditioned with RA at D0 to establish initial HOX gene expression patterns and commit cells to posterior identity; (2) Wnt3a is added at D3 to pre-activate signaling pathways before FGF8 is introduced; (3) The protocol pre-establishes the temporal sequence of HOX gene activation before final neuronal differentiation is triggered. These preliminary actions enable the accelerated 10-day protocol to achieve both speed and precision by pre-configuring the cellular state for rapid, controlled differentiation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the synchronous and efficient generation of human MN subtypes with precise rostro-caudal identities, overcoming previous limitations by dynamically encoding the HOX clock with extrinsic cues, thereby improving the control over cell fate specification and purity of MN populations.
Implementation Method 1
exposing human pluripotent stem cells to an activator of the Wnt signalling pathway to obtain axial progenitors
Implementation Method 2
exposing axial progenitors to retinoic acid (RA) and an agonist of the Hedgehog signalling pathway to obtain spinal motor neuron progenitors
Implementation Method 3
exposing axial progenitors to retinoic acid (RA) and an agonist of the Hedgehog signalling pathway
Implementation Method 4
the duration and combination of Wnt and Retinoic Acid exposure, along with Fibroblast Growth Factor (FGF) and Growth Differentiation Factor (GDF) signaling, control the temporal activation of HOX genes
Implementation Method 5
the duration and combination of Wnt and Retinoic Acid exposure, along with Fibroblast Growth Factor (FGF) and Growth Differentiation Factor (GDF) signaling
Data Source
AI summary
The present invention relates to the targeted engineering of specific cell populations. Motoneurons (MN) subtypes display differential vulnerabilities in diseases and in spinal injuries. Engineered MNs of specific rostro-caudal identity represent an important resource for cell therapy approaches. However, these strategies remain impeded by slow and inefficient targeted differentiations due to the imprecise control over cell fate specification in vitro. The inventors now used an embryoid body-based differentiation of hPSC and showed that the HOX clock expression can be controlled to generate subtypes of spinal MNs. Thus, the present invention relates to an in vitro or an ex vivo method for producing spinal neuronal subtypes comprising exposing axial progenitors to retinoic acid (RA), an agonist of Hedgehog signalling pathway, and optionally a FGFR agonist and/or an activator of the TGF pathway, wherein more and more caudal motor neurons identities are obtained by delayed exposure to RA and/or by exposure to RA in combination with the FGFR agonist and/or the activator of the TGF pathway.